1. Short article
- Author
-
Marta Grandal, Andrés Tabernilla, Álvaro Mena, Iria Rodríguez-Osorio, Ángeles Castro-Iglesias, Manuel Delgado, Eva Poveda, Berta Pernas, Purificación Cid, and José Pedreira
- Subjects
Hepatology ,business.industry ,Treatment duration ,Hepatitis C virus ,Gastroenterology ,virus diseases ,medicine.disease_cause ,Virology ,digestive system diseases ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Viral dynamics ,Medicine ,030211 gastroenterology & hepatology ,030212 general & internal medicine ,business ,Viral load ,Direct acting - Abstract
ObjectivesDirect-acting antiviral agents (DAAs) have provided an ultimate treatment duration of 12 weeks for most hepatitis C virus (HCV)-infected patients. The opportunity to reduce treatment duration to 6 or 8 weeks is being evaluated. Here, the HCV viral dynamics at short times during HCV therapi
- Published
- 2017
- Full Text
- View/download PDF